|
Society is evolving rapidly, especially in response to the COVID-19 pandemic. New technologies are changing the way we communicate, and vast amounts of information are readily available, introducing a new era of personalisation. This has resulted in patient needs becoming the focus of clinical studies. With patients taking more control of their own health and treatment options, the advantages and challenges of different trial methods are magnified.
A Patient-Centric Clinical Trial Model
The traditional method of patients visiting their clinical trial site to pick up medication can disrupt the patient’s day-to-day life. Today, this can be minimised by sponsors implementing a direct-to-patient (DtP) model into their study design.
With clinical supplies prepared, packaged, labelled, and then shipped directly to the home of the patient or caregiver, DtP ensures that trial participants are no longer required to visit the clinical site, which has become even more challenging in light of COVID-19.
|
